chr7-94528227-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_022900.5(CASD1):c.436C>G(p.Gln146Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000106 in 1,607,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022900.5 missense
Scores
Clinical Significance
Conservation
Publications
- myoclonic dystonia 11Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Illumina
- myoclonus-dystonia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151370Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000524 AC: 13AN: 248096 AF XY: 0.0000522 show subpopulations
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1455668Hom.: 0 Cov.: 29 AF XY: 0.0000124 AC XY: 9AN XY: 724346 show subpopulations
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151370Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 73898 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.436C>G (p.Q146E) alteration is located in exon 5 (coding exon 5) of the CASD1 gene. This alteration results from a C to G substitution at nucleotide position 436, causing the glutamine (Q) at amino acid position 146 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at